Venture
Arsenal Biosciences, Inc.
Latest Form D 2024-09-04- CIK 1945638
- State CA
- Biotechnology
- 3 Form D offerings since 2022-09-09
- Total sold
- $579M
- across 3 offerings
- Rounds
- 3
- Form D offerings since 2022-09-09
- Latest round
- $325M
- 2024-09-04 · 021-523129
- Investors
- 26
- on the latest round
Connected
named in its Form D filingsOfferings · since 2022-09-093 Form D offeringsExemptions506(b)People · Item 3Kenneth Drazan + 7 moreInvestors · dashboard1 inferred investor
Arsenal Biosciences, Inc.CIK 1945638
Round timeline
amount sold · by first filed2024-09-04 · $325M
- 2022-09-09$33M021-458444
- 2022-09-09$221M021-458499
- 2024-09-04$325M021-523129
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($325M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-523129 | First filed2024-09-04 | Latest2024-09-04 | Sought$325M | Sold$325M | Investors26 | Exemptions506(b) |
| 021-458499 | First filed2022-09-09 | Latest2022-09-09 | Sought$231M | Sold$221M | Investors17 | Exemptions506(b) |
| 021-458444 | First filed2022-09-09 | Latest2022-09-09 | Sought$33M | Sold$33M | Investors9 | Exemptions506(b) |
Who backs Arsenal Biosciences, Inc. — 1 inferred investor — and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2024-09-04
| Name | Relationship |
|---|---|
| Kenneth Drazan | RelationshipExecutive Officer, Director |
| James Ahlers | RelationshipExecutive Officer |
| Irene Pleasure | RelationshipExecutive Officer |
| Valentin Barsan | RelationshipDirector |
| Sean Parker | RelationshipDirector |
| Matthew Fust | RelationshipDirector |
| Brook Byers | RelationshipDirector |
| Beth Seidenberg | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2022-09-09
- Latest filing
- 2024-09-04
Who backs Arsenal Biosciences, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗